These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24041123)

  • 1. Peripherally selective diphenyl purine antagonist of the CB1 receptor.
    Fulp A; Bortoff K; Zhang Y; Snyder R; Fennell T; Marusich JA; Wiley JL; Seltzman H; Maitra R
    J Med Chem; 2013 Oct; 56(20):8066-72. PubMed ID: 24041123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenyl purine derivatives as peripherally selective cannabinoid receptor 1 antagonists.
    Fulp A; Bortoff K; Zhang Y; Seltzman H; Mathews J; Snyder R; Fennell T; Maitra R
    J Med Chem; 2012 Nov; 55(22):10022-32. PubMed ID: 23098108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists.
    Amato GS; Manke A; Vasukuttan V; Wiethe RW; Snyder RW; Runyon SP; Maitra R
    Bioorg Med Chem; 2018 Aug; 26(15):4518-4531. PubMed ID: 30077609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized 6-(Piperidin-1-yl)-8,9-Diphenyl Purines as Peripherally Restricted Inverse Agonists of the CB1 Receptor.
    Amato G; Manke A; Wiethe R; Vasukuttan V; Snyder R; Yueh YL; Decker A; Runyon S; Maitra R
    J Med Chem; 2019 Jul; 62(13):6330-6345. PubMed ID: 31185168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.
    Janero DR; Makriyannis A
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):43-65. PubMed ID: 19249987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.
    Griffith DA; Hadcock JR; Black SC; Iredale PA; Carpino PA; DaSilva-Jardine P; Day R; DiBrino J; Dow RL; Landis MS; O'Connor RE; Scott DO
    J Med Chem; 2009 Jan; 52(2):234-7. PubMed ID: 19102698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonist.
    Hadcock JR; Carpino PA; Iredale PA; Dow RL; Gautreau D; Thiede L; Kelly-Sullivan D; Lizano JS; Liu X; Van Deusen J; Ward KM; O'Connor RE; Black SC; Griffith DA; Scott DO
    BMC Pharmacol; 2010 Aug; 10():9. PubMed ID: 20712891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole antagonists of the CB1 receptor with reduced brain penetration.
    Fulp A; Zhang Y; Bortoff K; Seltzman H; Snyder R; Wiethe R; Amato G; Maitra R
    Bioorg Med Chem; 2016 Mar; 24(5):1063-70. PubMed ID: 26827137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
    Fride E; Ponde D; Breuer A; Hanus L
    Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.
    Chin CL; Tovcimak AE; Hradil VP; Seifert TR; Hollingsworth PR; Chandran P; Zhu CZ; Gauvin D; Pai M; Wetter J; Hsieh GC; Honore P; Frost JM; Dart MJ; Meyer MD; Yao BB; Cox BF; Fox GB
    Br J Pharmacol; 2008 Jan; 153(2):367-79. PubMed ID: 17965748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
    J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
    Tai S; Nikas SP; Shukla VG; Vemuri K; Makriyannis A; Järbe TU
    Psychopharmacology (Berl); 2015 Aug; 232(15):2751-61. PubMed ID: 25772338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
    Ting CH; Chi CW; Li CP; Chen CY
    Nutrition; 2015 Jan; 31(1):230-5. PubMed ID: 25466669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized 6-(piperidin-1-yl)-8,9-diphenyl purines as inverse agonists of the CB1 receptor - SAR efforts towards selectivity and peripheralization.
    Amato G; Wiethe R; Manke A; Vasukuttan V; Snyder R; Runyon S; Maitra R
    Bioorg Med Chem; 2019 Aug; 27(16):3632-3649. PubMed ID: 31301950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.